LAMISIL: TERBINAFINE HYDROCHLORIDE TABLET.
TERBINAFINE HYDROCHLORIDE TABLET. Key specifications include special_features: 1 PCT, primary_container_type: TUBE, supplementary_features: 250 MG; 30 TABELTS PER BOTTLE, therapeutic_equivalent: TO LAMISIL BY SANDOZ, secondary_container_type: BOTTLE, primary_container_content_quantity: 30.0 TABLETS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-373-1442, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 1 PCT |
| primary_container_type | TUBE |
| supplementary_features | 250 MG; 30 TABELTS PER BOTTLE |
| therapeutic_equivalent | TO LAMISIL BY SANDOZ |
| secondary_container_type | BOTTLE |
| primary_container_content_quantity | 30.0 TABLETS |
| part_name_assigned_by_controlling_agency | TERBINAFINE HYDROCHLORIDE TABLETS 250MG 30S BT |
| NSN | 6505-01-373-1442 |
| THERAPEUTIC EQUIVALENT | TO LAMISIL BY SANDOZ |
| PRIMARY CONTAINER CONTENT QUANTITY | 15.000 GRAMS G |
| PRIMARY CONTAINER TYPE | TUBE |
| SPECIAL FEATURES | 1 PCT |